NCT00375661已完成4 期
Phase 4 Study of Peg-interferon Plus Ribavirin Therapy for Prevention of Hepatocellular Carcinoma
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Incidence of adverse effect of interferon
研究概览
简要总结
The purpose of this study is to determine whether low-dose peg-interferon plus ribavirin therapy is effective in the prevention of hepatocellular carcinoma (HCC) in patients who had the curative resection of primary HCC.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of Hepatocellular carcinoma due to Chronic Hepatitis C Virus Infection.
- •Must be treated with curative treatment for primary tumor using either surgical resection or radiofrequency ablation therapy
排除标准
- •No recurrence of hepatocellular carcinoma 3 months after the primary treatment
- •Renal dysfunction
研究组 & 干预措施
interferon
No Intervention
干预措施: interferon-alfa-2b and ribavirin (Drug)
结局指标
主要结局
Incidence of adverse effect of interferon
时间窗: During the treatment period
次要结局
未报告次要终点
研究者
Hiroyuki Marusawa
Associate professor
Kyoto University
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3Hepatitis CNCT00056862National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)58
已完成
4 期
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney DiseaseChronic Hepatitis CNCT00028093National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)50
已完成
2 期
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)Hepatitis CHIV InfectionsNCT00008463National Institute of Allergy and Infectious Diseases (NIAID)132
已完成
4 期
A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 InfectionHepatitis C, ChronicNCT00192647Hoffmann-La Roche896
已完成
不适用
Efficacy of pegylated interferon plus ribavirin lead-in therapy on telaprevir with pegylated interferon plus ribavirin therapy for aged patients with chronic hepatitis C genotype 1Chronic hepatitis CJPRN-UMIN000007329Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine410